The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

2017 • 28,714 citations

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

2016 • 11,500 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

2005 • 6,633 citations

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

2010 • 5,696 citations

Clinical epidemiology of cardiovascular disease in chronic renal disease

1998 • 3,896 citations

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

2010 • 3,658 citations

Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

2005 • 2,496 citations

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1976 • 2,290 citations

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1975 • 2,224 citations

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

2008 • 1,939 citations

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

2009 • 1,901 citations

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

2008 • 1,529 citations

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

2003 • 893 citations

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

2002 • 565 citations

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

2010 • 545 citations

Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease

2007 • 501 citations

Ezetimibe

2005 • 436 citations

Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease

2004 • 371 citations

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

2010 • 306 citations

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

2008 • 306 citations

K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease

2003 • 253 citations

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

2005 • 202 citations

The Second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: A Randomized Controlled Study of the Biochemical Safety and Efficacy of Adding Ezetimibe to Simvastatin as Initial Therapy Among Patients With CKD

2006 • 108 citations

K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.

2003 • 101 citations

Estimating the effect of the run‐in on the power of the physicians' health study

1991 • 97 citations